Polymer-drug conjugates
AssigneePrimelink Biotherapeutics (Shenzhen) Co., Ltd
InventorsMao YIN, Xianhua YI, Yingdong LU, Xiaohe SHI, Ling XIN, Guangchao ZHANG, Jiani YU, Yu SHEN
Life of this patent
Estimating the term…
Abstract
A polymeric scaffold useful for conjugating with a targeting moiety can form a targeting moiety-polymer-drug conjugate. A targeting moiety-polymer-drug conjugate is prepared from the polymeric scaffold. Compositions comprise the conjugates. Methods of their preparation and methods of treating various disorders with the conjugates or their compositions.
Claims69
A polymeric scaffold of Formula (I) useful to conjugate with a targeting moiety:
- wherein:
- the polymeric scaffold comprises linear polyglycerol;
- L is a linking moiety comprising a functional group Wp that is capable of forming a covalent bond with the targeting moiety;
- Ma is a stretcher connecting L to —NH— moiety;
- each G1 is independently a functional group connecting Lp to the linear polyglycerol;
- each Lp is independently a drug release mechanism between a therapeutic agent moiety D and G1;
- each D is independently a therapeutic agent moiety;
- each G2 is independently a functional group capable of converting into a charged state;
- n is an integer from 0 to 1000;
- m is an integer from 0 to 1000;
- p is an integer from 0 to 1000;
- and
- q is an integer from 0 to 1000.
A polymeric scaffold of Formula (II):
- wherein,
- the polymeric scaffold comprises linear polyglycerol;
- L is a linking moiety comprising a functional group Wp that is capable of forming a covalent bond with the targeting moiety;
- Ma is a stretcher connecting L to —NH— moiety;
- each G2 is independently a functional group capable of converting into a charged state;
- each G3 independently comprises a functional group capable of reacting with a reactive group in a drug release mechanism to connect the drug release mechanism to the linear polyglycerol;
- n is an integer from 0 to 1000;
- m is an integer from 0 to 1000;
- p is an integer from 0 to 1000;
- and
- q is an integer from 0 to 1000.
The polymeric scaffold of claim 55, wherein
- n is 2;
- m is 2;
- and
- p is 2.
The polymeric scaffold of claim 55, wherein q is an integer from 3 to 5.
The polymeric scaffold of claim 55, wherein G2 and G3 are independently selected from the group insisting of:
- in which, each R17 is independently selected from a direct bond, alkyl, cycloalkyl, heterocycloalkyl, aryl or heteroaryl.
The polymeric scaffold of claim 55, having a structure of Formula (IIIa) or (IIIb):
The polymeric scaffold of claim 55, having a weight average molecular weight Mw of 1-100000.
The polymeric scaffold of claim 55, having a weight average molecular weight Mw of 10000-15000.
The polymeric scaffold of claim 55, having a weight average molecular weight Mw of 5000-10000.
The polymeric scaffold of claim 55, having a PDI of less than 1.5.
A polymeric scaffold of Formula (IV):
- wherein,
- the polymeric scaffold comprises linear polyglycerol;
- each La is independently a divalent moiety connecting the targeting moiety to Ma;
- each Ma is independently a stretcher connecting La to —NH— moiety;
- each G1 is independently a functional group connecting Lp to the linear polyglycerol;
- each Lp is independently a drug release mechanism between a fragment of a therapeutic agent D and G1;
- each D is independently a fragment of a therapeutic agent;
- each G2 is independently a functional group capable of converting into a charged state;
- n is an integer from 0 to 1000;
- m is an integer from 0 to 1000;
- p is an integer from 0 to 1000;
- q is an integer from 0 to 1000;
- and
- s is an integer from 1 to 8.
Dependencies are inferred from the claim text.